ATE456956T1 - Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln - Google Patents

Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln

Info

Publication number
ATE456956T1
ATE456956T1 AT03727053T AT03727053T ATE456956T1 AT E456956 T1 ATE456956 T1 AT E456956T1 AT 03727053 T AT03727053 T AT 03727053T AT 03727053 T AT03727053 T AT 03727053T AT E456956 T1 ATE456956 T1 AT E456956T1
Authority
AT
Austria
Prior art keywords
methods
photosensitized
drugs
delivering
compositions
Prior art date
Application number
AT03727053T
Other languages
English (en)
Inventor
Eric Allemann
Yvette Konan
Robert Gurny
Ronald Boch
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE456956T1 publication Critical patent/ATE456956T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03727053T 2002-05-16 2003-05-16 Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln ATE456956T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38147402P 2002-05-16 2002-05-16
PCT/CA2003/000740 WO2003097096A1 (en) 2002-05-16 2003-05-16 Compositions and methods for delivery of photosensitive drugs

Publications (1)

Publication Number Publication Date
ATE456956T1 true ATE456956T1 (de) 2010-02-15

Family

ID=29550129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03727053T ATE456956T1 (de) 2002-05-16 2003-05-16 Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln

Country Status (8)

Country Link
US (1) US7455858B2 (de)
EP (1) EP1503796B1 (de)
AT (1) ATE456956T1 (de)
AU (1) AU2003233287A1 (de)
CA (1) CA2484664C (de)
DE (1) DE60331185D1 (de)
ES (1) ES2341646T3 (de)
WO (1) WO2003097096A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534811A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク ポリマーと薬剤の集合体を含む医薬組成物
US7133547B2 (en) * 2002-01-24 2006-11-07 Tripath Imaging, Inc. Method for quantitative video-microscopy and associated system and computer software program product
EP1730516A1 (de) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Verfahren und vorrichtung zur bewertung pharmazeutischer zusammensetzungen
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
US20090304803A1 (en) * 2005-06-06 2009-12-10 The General Hospital Corporation Compositions and methods relating to target-specific photodynamic therapy
WO2007127799A2 (en) * 2006-04-25 2007-11-08 Research Foundation Of The City University Of New York Polymer submicron particle preparation by surfactant- mediated precipitation
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8703204B2 (en) * 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2162120B1 (de) * 2007-06-04 2016-05-04 Bend Research, Inc Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer
EP2178518A2 (de) * 2007-07-13 2010-04-28 Bend Research, Inc Nanopartikel mit ionisierbaren und schwach wasserlöslichen zellulose-polymeren
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2153821A1 (de) * 2008-08-06 2010-02-17 BioAlliance Pharma Orale Formulierungen von Camptothecin-Derivaten
EP2198885B1 (de) 2008-12-19 2012-02-08 Biolitec AG Kalziumphosphat-Nanopartikel als Farbstoffträger für die photodynamische Therapie
US8815931B2 (en) * 2009-04-28 2014-08-26 Biolitec Pharma Marketing Ltd Oral formulations for tetrapyrrole derivatives
US9211283B2 (en) * 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
US20110275686A1 (en) 2009-12-11 2011-11-10 Biolitec, Inc. Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
KR101892785B1 (ko) * 2011-08-11 2018-10-04 퀘스트 파마테크 인코포레이티드 감광제를 위한 폴리머 나노입자
US20160082127A1 (en) * 2013-05-18 2016-03-24 Dcb-Usa Llc Photosensitizer particles for medical imaging and/or photodynamic therapy
US20170119814A1 (en) * 2014-06-17 2017-05-04 Albert Einstein College Of Medicine, Inc. Therapeutic nanoparticles and methods thereof
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
CN116832158A (zh) 2015-07-21 2023-10-03 艾维德洛公司 用光敏剂治疗眼睛的系统和方法
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
ATE84806T1 (de) 1987-04-16 1993-02-15 Christian Bindschaedler Verfahren zur herstellung eines wasserunloeslichen polymerpulvers, das in einer fluessigen phase redispergiert werden kann und verfahren zur herstellung einer dispersion des polymerpulvers.
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
AU7127196A (en) 1995-09-21 1997-04-09 Novartis Ag Nanoparticles in photodynamic therapy
US20020127224A1 (en) 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy

Also Published As

Publication number Publication date
US20040047913A1 (en) 2004-03-11
EP1503796A1 (de) 2005-02-09
WO2003097096A1 (en) 2003-11-27
DE60331185D1 (de) 2010-03-25
EP1503796B1 (de) 2010-02-03
ES2341646T3 (es) 2010-06-24
AU2003233287A1 (en) 2003-12-02
CA2484664C (en) 2010-07-06
US7455858B2 (en) 2008-11-25
CA2484664A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
ATE456956T1 (de) Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
CY1111263T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει sns-595 και χρησεις αυτης
CY1106601T1 (el) Χρηση του παραγωγου κουιναζολινης zd6474 συνδυασμενου με γκεμσιταμπινη και προαιρετικα με ιοντιζουσα ακτινοβολια στη θεραπεια του καρκινου
LUC00011I1 (de)
SG166775A1 (en) Combinations and modes of administration of therapeutic agents and combination therapy
CY1110162T1 (el) Φαρμακοτεχνικη μορφη και μεθοδοι για την αγωγη της θρομβοκυτταραιμιας
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
DE60033649D1 (de) Verbindungen und therapeutische methoden
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE602004016754D1 (de) Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
ATE272400T1 (de) Verwendung von tryptophan-derivaten zur spezifischen zytostatischen behandlung von serotonin-produzierenden tumoren
ATE338560T1 (de) Pharmazeutische zusammentsetzung zur medizinischen behandlung von gutartiger prostathyperplasie, dessen vorbereitungsmethode und dessen therapeutische verwendung
ATE411313T1 (de) Neue makrocyclen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties